Hepatic encephalopathy: pathophysiology and advances in therapy

Area of Science:

• Neuroscience
• Hepatology
• Gastroenterology

Background:

• Hepatic encephalopathy (HE) is a significant neuropsychiatric complication associated with cirrhosis.
• HE can manifest in acute liver failure, distinct from cirrhotic cases, sometimes without portosystemic shunting.

Purpose of the Study:

• To provide updated information on the classification of hepatic encephalopathy.
• To review current theories regarding the pathophysiological basis of HE.
• To evaluate existing therapeutic strategies for managing HE.

Main Methods:

• Literature review of recent studies on hepatic encephalopathy.
• Analysis of classification systems for HE.
• Evaluation of pathophysiological mechanisms, particularly the role of ammonia.
• Assessment of current and emerging ammonia-lowering therapies.

Main Results:

• Hepatic encephalopathy pathogenesis is multifactorial, with ammonia identified as a primary causative agent.
• Current management strategies focus on reducing ammonia levels.
• Key ammonia-lowering interventions include dietary protein management and medications such as lactulose, neomycin, sodium benzoate, and L-ornithine-aspartate.

Conclusions:

• Hepatic encephalopathy requires a comprehensive understanding of its classification and pathophysiology.
• Ammonia-lowering strategies remain the cornerstone of prevention and treatment for HE in cirrhotic patients.
• Further research is needed to refine therapeutic approaches for this complex condition.